Rapid molecular detection of CMY-2, and CTX-M group 1 and 9 variants via recombinase polymerase amplification.

Nicole G ErtlAdam David IrwinJoanne MacdonaldMichelle J BauerClaire Y T WangPatrick N A HarrisClaire HeneyHosam M ZowawiDavid M Whiley

Published in: JAC-antimicrobial resistance (2023)

RPA-LF assays developed in this study have the potential to be used at or close to the point of care, as well as in low-resource settings, producing rapid results to support healthcare professionals in their treatment decisions.

Keyphrases

high throughput
copy number
nucleic acid
combination therapy
escherichia coli
genome wide
replacement therapy